Hyperfine, Inc.
HYPR NasdaqΒ· Electromedical & Electrotherapeutic Apparatus
Last close Β· Oct 23, 2026
$0.72
KIRA Β· Stoqlyβs AI analyst, in plain words
- Hyperfine, Inc. had $13.6M of revenue in fiscal 2025, up 5.2% on the year before. Over five years, revenue changed +115.2% a year on average.
- Its operating margin was β273.4%, up 61.9Β pts: of every 100 in sales, about β273 is left after running the business.
- Hyperfine, Inc. lost $35.6M in fiscal 2025.
- Free cash flow was β$29.1M in fiscal 2025, β214.8% of revenue.
- Hyperfine, Inc. has $35.1M more cash than debt.
Market cap
$72.3M
P/E
β
Revenue
$13.6M
Net income
β$35.6M
Free cash flow
β$29.1M
Operating margin
β273.4%
Hyperfine, Inc. in 30 seconds Β· fiscal 2025
Are sales growing?
+5.2%
Yes. Sales grew 5.2% last year.
Does it make a profit?
β262.3%
No. It lost money last year.
Does profit turn into cash?
β214.8%
No. It spent more cash than it brought in.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
What Hyperfine, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 18, 2026
- Legal name
- Hyperfine, Inc.
- CIK
- 0001833769
Hyperfine, Inc. Β· HYPR
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $1.5M | $6.8M | $11.0M | $12.9M | $13.6M |
| Revenue growth | 408.8% | 355.5% | 61.9% | 16.8% | 5.2% |
| Gross margin | β78.0% | 13.3% | 43.1% | 45.7% | 49.8% |
| Operating margin | β4,336.1% | β1,084.2% | β436.1% | β335.3% | β273.4% |
| Net income | β$64.9M | β$44.2M | β$44.2M | β$40.7M | β$35.6M |
| Net margin | β4,335.0% | β649.2% | β401.0% | β315.9% | β262.3% |
| Diluted EPS | β$17.57 | β$1.04 | β$0.62 | β$0.56 | β$0.43 |
| Cash | |||||
| Cash from operations | β$47.2M | β$72.3M | β$41.8M | β$38.8M | β$27.9M |
| Capital expenditure | $2.7M | $0.6M | $0.8M | $0.4M | $1.2M |
| Free cash flow | β$49.9M | β$72.9M | β$42.6M | β$39.2M | β$29.1M |
| FCF margin | β3,335.1% | β1,070.2% | β386.3% | β303.7% | β214.8% |
| Share count change | 142.3% | 1,808.9% | 1.2% | 1.5% | 13.0% |
| Debt and strength | |||||
| Cash and short-term investments | $188M | $117M | $75.2M | $37.6M | $35.1M |
| Debt incl. finance leases | β | β | β | β | $0.0M |
| Shareholders' equity | $186M | $124M | $84.4M | $49.0M | $41.0M |
| Current ratio | 12.5x | 14.6x | 10.1x | 6.2x | 4.3x |
| Returns and quality | |||||
| Return on capital | β | β | β | β | β494.9% |
| Return on equity | β103.6% | β28.5% | β42.5% | β61.0% | β79.0% |
| Return on tangible equity | β34.8% | β59.1% | β52.4% | β83.0% | β86.8% |
| Piotroski F-score | 4 | 3 | 3 | 3 | 4 |
| Altman Z'' | 13.6 | 9.6 | 2.4 | β11.0 | β16.3 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.1M
2 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Hyperfine, Inc. Β· HYPR
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $0.72 a share, the company is worth $72.3M.
Source: SEC EDGAR XBRL filings (CIK 0001833769). Data updated October 24, 2026. For information only β not investment advice. Check the original filings before relying on any figure.
